BioLert
Medical Device for Epilepsy
Company Overview
Snapshot
Founded in January 2010, BioLert operates with 1–10 employees and has raised $130,000 across one funding round. The company's first product line, EpiLert, is targeted at the epilepsy market, focusing on remote monitoring solutions.
Business overview
BioLert Electro Medical Systems develops and manufactures medical devices for vital sign monitoring, with a primary focus on the epilepsy market. The company's core technology involves an electro-medical device that combines smartwatch technology, a smartphone, and a patented algorithm to continuously monitor and detect seizure events. This solution aims to increase independence and self-confidence for individuals with seizures by notifying specified contacts in the event of a severe nervous system event. BioLert operates within the Health Tech & Life Sciences sector, specifically in Digital Healthcare and Medical Devices, serving patients and healthcare providers globally.
Strategic signal
In January 2012, BioLert secured a grant for its EpiLert product, indicating early validation for its epilepsy monitoring technology. This milestone underscored the potential of its patented algorithm and smartwatch-based solution to address critical needs in remote patient monitoring for neurological conditions, signaling investor confidence in its innovative approach to digital healthcare.
Company Intelligence Q&A
- What is BioLert's primary focus?
- BioLert Electro Medical Systems is dedicated to developing and manufacturing medical devices for monitoring vital signs, primarily targeting the epilepsy market with its EpiLert product line.
- What technology does BioLert utilize for seizure detection?
- BioLert develops an electro-medical device that integrates smartwatch technology, a smartphone, and a patented algorithm to continuously monitor for and detect seizure events, providing remote monitoring capabilities for patients and caregivers.
- When was BioLert founded?
- BioLert was founded in January 2010.
- What was a significant early milestone for BioLert?
- In January 2012, BioLert received a grant for its EpiLert product, which is designed for epilepsy monitoring.
- What is the current operational status of BioLert?
- BioLert is currently Non Active, having ceased to operate in January 2021.